GB2328942A - Side chain synthesis for an antiarrythmic compound - Google Patents

Side chain synthesis for an antiarrythmic compound Download PDF

Info

Publication number
GB2328942A
GB2328942A GB9818661A GB9818661A GB2328942A GB 2328942 A GB2328942 A GB 2328942A GB 9818661 A GB9818661 A GB 9818661A GB 9818661 A GB9818661 A GB 9818661A GB 2328942 A GB2328942 A GB 2328942A
Authority
GB
United Kingdom
Prior art keywords
compound
formula
side chain
reaction
displacement
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GB9818661A
Other versions
GB9818661D0 (en
Inventor
Joseph E Lynch
Yao-Jun Shi
Kenneth M Wells
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9810549.7A external-priority patent/GB9810549D0/en
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of GB9818661D0 publication Critical patent/GB9818661D0/en
Publication of GB2328942A publication Critical patent/GB2328942A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D243/00Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/141,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/161,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C07D243/181,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
    • C07D243/24Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C201/00Preparation of esters of nitric or nitrous acid or of compounds containing nitro or nitroso groups bound to a carbon skeleton
    • C07C201/06Preparation of nitro compounds
    • C07C201/08Preparation of nitro compounds by substitution of hydrogen atoms by nitro groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C201/00Preparation of esters of nitric or nitrous acid or of compounds containing nitro or nitroso groups bound to a carbon skeleton
    • C07C201/06Preparation of nitro compounds
    • C07C201/12Preparation of nitro compounds by reactions not involving the formation of nitro groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/347Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups
    • C07C51/377Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups by splitting-off hydrogen or functional groups; by hydrogenolysis of functional groups
    • C07C51/38Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups by splitting-off hydrogen or functional groups; by hydrogenolysis of functional groups by decarboxylation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00Preparation of carboxylic acid esters
    • C07C67/30Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
    • C07C67/333Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton
    • C07C67/343Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The present invention is directed to an improved process for preparing the phenylacetic acid side chain of the compound of the formula This compound exhibits utility as a Class III antiarrhythmic agent.

Description

TrrLE OF THE INVENTION SIDE CHAIN SYNTHESIS FOR AN ANTIARRHYTHMfC COMPOUND BACKGROUND OF ThE INVENTION This invention relates to a process for preparing the side chain of a Class III antiarrhythmic compound of the kind disclosed in U.S. Patent No. 5,426,185. The previous method to prepare the side chain relied on a -78 C metalation reaction that would be difficult and expensive to use on a commercial scale. This process employs a novel aromatic nitro group displacement to generate a key intermediate in the synthesis of the side chain.
Arrhythmias often occur as complications to cardiac diseases such as myocardial infarction and heart failure. In a serious case, arrhythmias give rise to a ventricular fibrillation and can cause sudden death.
Though various antiarrhythmic agents are now available on the market, agents which exhibit both satisfactory effects and high safety profiles have not been marketed. For example, antiarrhythmic agents of Class I, according to the classification of Vaughan-Williams, which cause a selective inhibition of the maximum velocity of the upstroke of the action potential (Vmax) are inadequate for preventing ventricular fibrillation. In addition, they have problems regarding safety, namely, they cause a depression of the myocardial contractility and have a tendency to induce arrhythmias due to an inhibition of the impulse conduction. Beta-adrenoceptor blockers and calcium antagonists which belong to Class H and IV respectively, have a defect in that their effects are either limited to a certain type of arrhythmia or are contraindicated because of their cardiac depressant properties in certain patients with cardiovascular disease. Their safety, however, is higher than that of the antiaiythmic agents of Class I.
Antiarrhythmic agents of Class III are drugs which cause a selective prolongation of the duration of the action potential without a significant depression of the Vmax. Drugs in this class are lirnited.
Examples such as sotalol and amiodarone have been shown to possess Class III properties. Sotalol also possesses Class II effects which may cause cardiac depression and be contraindicated in certain susceptible patients. Also, amiodarone is severely limited by side effects. Drugs of this class are expected to be effective in preventing ventricular fibrillations. Pure Class III agents, by definition, are not considered to cause myocardial depression or an induction of arrhythmias due to the inhibition of the action potential conduction as seen with Class I antiarrhythmic agents.
SUMMARY OF THE INVENTION There is disclosed a novel process for preparing the phenylacetic acid side chain for the compound of the formula
This compound has been found to show utility as a Class III antiarrhythmic agents.
DETAILED DESCRIPTION OF THE INVENTION The present invention is directed to a novel four-step process for preparing the side chain for Compound 1 through the displacement of an aromatic nitro group with dimethyl malonate. The previous process relied on a a -78 C metalation reaction that due to the extremely low temperaure requirement, would be difficult to employ on a commercial scale.
Throughout the specification and appended claims, a given chemical formula or name shall encompass all optical and stereoisomers as well as racemic mixtures where such isomers and mixtures exist.
The term alkyl refers to straight, branched or cyclic chain hydrocarbon groups, e.g., methyl, ethyl, n-propyl, isopropyl, n-butyl, pentyl, hexyl, heptyl, cyclopentyl, cyclohexyl, cyclohexylmethyl and the like.
The term alkoxy refers to straight or branched chain oxyalkyl groups such as, e.g., methoxy, ethoxy, butoxy, heptoxy, dodecyloxy, and the like.
Pharmaceutically acceptable salts suitable as acid addition salts are those from acids such as hydrochloric, hydrobromic, phosphoric, sulfuric, maleic, citric, acetic, tartaric, succinic, oxalic, malic, glutamic and the like, and include other acids related to the pharmaceutically acceptable salts listed in Journal of Pharmaceutical Science, 66:2 (1977).
Generally, the process of the invention comprises the following steps a) nitration of compound 2 of the formula
to afford compound 3 of the formula
b) reaction of compound 3 with trifluoromethyl copper to afford compound 4 of the formula
c) displacement of the nitro of compound 4 with dimethyl malonate to afford compound 5 of the formula
d) which is subsequently hydrolyzed and decarboxylated to afford compound 6, the 2 ,4-bis (trifluoromethyl)phenylacetic acid side chain of the formula,
The side chain is attached to the benzodiazepine nucleus of Compound 1 as shown below.
F3C CF3' o1 + HO N 4 NH2 -(R)-Mandelic CF3 tN = Mandelic CF3 Acid 6 NI F3CA 0 CF3 1) Acid Chloride, > N oi KHCO3 (aq)fiPAc; 44 CFs N NH CF3 N
The invention is illustrated in the following steps wherein preferred reactants are shown to more clearly demonstrate the process disclosed.
As shown above, Step 1 involves the nitration of commercially available starting material 3 -iodobenzotrifluoride in nitric or other suitable acids. The reaction takes place at a temperature range of about 0 C to about 80"C over 0.5 to 5 hours. Preferred conditions include a temperature range of about 20"C to about 35"C over 2 to 3 hours. Particularly preferred conditions are 20"C for 2 hours.
A hexane wash following the nitration step is critical to remove unwanted regioisomers.
Step 2 involves the trifluoromethylation of Compound 3 as described in Chen et al., Tet. Lett., 1991, 7689. Iodobenzene compound 3 is reacted with methyl chlorodifluoroacetate with copper iodide in the presence of potassium fluoride. DMF or other suitable solvent such as n-methyl pyrrolidinone or n-ethyl pyrrolidinone can be used The reaction takes place at a temperature range of about 90"C to about 1300C over 1 to 10 hours. Preferred conditions include a temperature of about 103"C for 4 hours.
In Step 3 the nitro substituent on compound 4 is displaced by reaction with dimethyl malonate to provide compound 5, the dimethyl ester. The reaction could use any alkyl malonate to prepare any alkyl ester. However, the dimethyl malonate is preferred. The reaction takes place in the presence of potassium butoxide or other suitable base. DMF or other suitable solvents such as n-methyl pyrrolidinone can be used. The displacement reaction takes place at a temperature range of about -10 C to about 75"C over 1 to 48 hours.
Preferably, the displacement reaction takes place at a temperature range of about 15"C to about 30"C over 20 to 30 hours.
The hydrolysis and decarboxylation of Compound 5 is accomplished using an acid such as aqueous HCl in acetic acid. This reaction takes place at a temperature range of about 75"C to about 1500C over 1 to 24 hours. Preferably, the reaction takes two hours at 100"C to give the side chain in high assay yield.
Following the synthesis of the side chain, it is can be coupled, as described above, to prepare Compound 1.
The invention is described in greater detail in the following examples in which all parts, preparations, ratios and percentages are by weight unless otherwise indicated. These are for illustrative purposes and are not to be construed as limiting the invention described and claimed herein. All temperatures are given in degrees centigrade ("C) unless otherwise noted.
EXAMPLE 1 (1) Nitration
Materials Amounts Moles 3-iodobenzotrifluoride (2); 377 gms 1.39 90% Nitric acid; 1 L To a 4-neck 22 L round bottom flask with a mechanical stirrer, thermocouple, heating mantle and N2 inlet containing 90% nitric acid was added 3-iodobenzotrifluoride (2) over 15 minutes at 20 "C. A mild exotherm was observed. The reaction mixture was stirred at 20 "C for two hours after which time no 3-iodobenzotrifluoride (2) was observed by LC. The reaction mixture was slowly added to 1L ice water. The slurry was stirred for 30 minutes and filtered. The solids were washed with hexanes (2 X 150 ml). 240 grams (55%) of solid was obtained and used directly in the next step.
The hexane wash removed the undesired isomer 7 as well as 6 and about 10% of the desired 3. The conversion of 2 to products was monitored by LC by adding -5ul of the reaction niixture to 1.5 ml CH3CN. The LC conditions: Zorbax Rx-C8, 4.6 x 250 mm, 65:35 =CH3CN:H20 (0.1% H3PO4), Flow rate = 1.0 ml/min., at 220 nm, Rt = 8.3 min (for 2); 7.6 min (for 3).
EXAMPLE 2 (2) Trifluoromethylation
Materials Amounts Moles 4-Nitro-3-trifluoro 150 gms 0.47 methyliodobenzene (3); Copper iodide 36 gms 0.19 Methylchlorodifluoroacetate 205 gms 1.42 Potassium fluoride 55 gms 0.95 Dimethylformamide 750 ml To a 3-neck 2 L round bottom flask with a mechanical stirrer, thermocouple, heating mantle, condenser, addition funnel and N2 inlet was charged 4-nitro-3-trifluoromethyliodobenzene (3) and DMF. 50 grams methyl chlorodifluoroacetate, copper iodide and potassium fluoride were added and the reaction mixture was heated to 103 "C The remaining methyl chlorodifluoroacetate was added via addition funnel over 1 hour. After four hours at 103"C all starting material was consumed. The reaction solution was cooled to room temperature and poured into 1L H20/ 50 ml NH40H. Extracted with EtOAc (2 x 400 ml) and the combined organics were washed with water (3 x 500 ml). The organics were evaporated and flushed with EtOAc (3 x 250 ml) to remove water. The crude oil was assayed (85. 3 g of 4, 70% yield) and used directly in the next step.
EXAMPLE 3 (3) Nitro-displacement
Materials Amounts Moles Bis(trifluoromethyl)nitro 20.4 gms 0.08 benzene 4 Dimethyl malonate 31.3 gms 0.24 Potassium t-butoxide 26.6 gms 0.24 Dimethylformarnide 183 ml To a 3-neck 1 L round bottom flask with a mechanical stirrer, thermocouple, cooling bath, addition funnel and N2 inlet was charged dimethyl malonate and DMF. The solution was cooled to 15"C.
Potassium t-butoxide was added over 15 minutes as a solid. A solution of Bis(trifluoromethyl)nitrobenzene 4 (in 20 ml of DMF) was added via addition funnel over 10 minutes. The reaction mixture was warmed to room temperature and aged overnight. LC assay showed consumption of 4 and the reaction was quenched into 500 ml water. The quenched solution was extracted with EtOAc (2 x 400 ml) and the combined organics washed with water (3 x 500 ml). The resulting solution was assayed (18.8 g of 5, 70% yield) and solvent switched to AcOH for use in the next step.
EXAMPLE 4 (4) Hydrolysis/Decarboxylation
Materials knounts mInol Dimethylester 5 10.0 g 29.1 Acetic Acid 50 ml HCl (conc) 10 ml Water SmI Hexane 30 ml To a 3-neck 250 ml round bottom flask with a mechanical stirrer, thermocouple, heating mantle and N2 inlet was charged dimethyl ester S with acetic acid, conc. HCl and water. The resulting solution was heated to 100"C for six hours. LC assay indicated that 5 had been consumed and the reaction was quenched into 100 ml water.
The quenched solution was extracted with EtOAc (2 x 100 ml) and the combined organics washed with water (3 x 100 ml). The resulting solution was assayed and solvent switched to hexane (30 ml). The slurry was heated to 50"C to dissolve all solids. The solution was slowly cooled to 20"C. The slurry was filtered and washed with hexane (3 ml).
The solids were dried and 4.7 grams (60%) of a solid were obtained.
The mother liquors contained 10% of the phenylacetic acid 6.
EXAMPLE 5 (4) Coupling
1) Acid Chloride, F30i̇ 0 o'# CF3 NH2 Acid Chloride, > S NH N N - (R)-Mandelic ) (44 NJI tF Acid N Acid MW = 587.5 MW =485.5 MW = 485.5 Materials Amounts Acid chloride (in i-PAc) 10.67 g Aminobenzodiazepam mandelate salt 16.77 g KHCO3 18.39 g i-PAc/H20 170ml/150ml iPAC 150 ml i-PrOH 95.0 ml H2O 95.0 ml The mandelate salt (10 ml/g) was charged into the reaction vessel, followed by addition of i-PAc and aqueous KHCO3 [KHCO3 (18.4 gms)/water (150 ml)] at 20"C. The slurry was stirred at 20-22"C for 5-10 min followed by addition of the acid chloride solution (ca. 25 ml) over 15 min. at 20-22"C (a slight exothenn was observed). The mixture was stirred at 22"C for one hour and LC assay showed the completion of the reaction. The layers was separated and the organic layer was washed with 50% saturated NaHCO3 (100 ml x 3) and with water (100 ml x 2).
The crude product was recrystallized from i-PrOH/H20 to afford Compound 1.

Claims (4)

WHAT IS CLAIMED IS:
1. A process for the synthesis of the compound of the formula
which comprises the steps of a) nitration of compound 2 of the formula
to afford compound 3 of the formula
b) reaction of compound 3 with trifluoromethyl copper to afford compound 4 of the formula
c) displacement of the nitro of compound 4 to afford compound 5 of the formula
d) which is subsequently hydrolyzed and decarboxylated to afford compound 6.
2. The process of Claim 1 wherein the nitro displacement in Step (c) is accomplished using dimethyl malonate.
3. The process of Claim 2 wherein the displacement reaction takes place at a temperature of about 15"C to about 30"C over 20 to 30 hours.
4. The process of Claim 1 wherein following the nitration of compound 2, the reaction mixture undergoes a hexane wash in order to remove unwanted regioisomers of compound 3.
GB9818661A 1997-09-05 1998-08-27 Side chain synthesis for an antiarrythmic compound Withdrawn GB2328942A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5806097P 1997-09-05 1997-09-05
GBGB9810549.7A GB9810549D0 (en) 1998-05-15 1998-05-15 Side chain synthesis for an antiarrhythmic compound

Publications (2)

Publication Number Publication Date
GB9818661D0 GB9818661D0 (en) 1998-10-21
GB2328942A true GB2328942A (en) 1999-03-10

Family

ID=26313696

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9818661A Withdrawn GB2328942A (en) 1997-09-05 1998-08-27 Side chain synthesis for an antiarrythmic compound

Country Status (1)

Country Link
GB (1) GB2328942A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1077208A2 (en) * 1999-08-16 2001-02-21 Bayer Ag Process for the preparation of (bis-(trifluormethyl)-phenyl)-acetic acids and their alkyl esters as well as dialkyl esters of (bis-(trifluormethyl)-phenyl)-malonic acid

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996005839A1 (en) * 1994-08-18 1996-02-29 Merck & Co., Inc. 2,3-dihydro-1-(2,2,2-trifluoroethyl)-2-oxo-5-phenyl-1h-1,4-benzodiazepines

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996005839A1 (en) * 1994-08-18 1996-02-29 Merck & Co., Inc. 2,3-dihydro-1-(2,2,2-trifluoroethyl)-2-oxo-5-phenyl-1h-1,4-benzodiazepines

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1077208A2 (en) * 1999-08-16 2001-02-21 Bayer Ag Process for the preparation of (bis-(trifluormethyl)-phenyl)-acetic acids and their alkyl esters as well as dialkyl esters of (bis-(trifluormethyl)-phenyl)-malonic acid
EP1077208A3 (en) * 1999-08-16 2003-01-02 Bayer Ag Process for the preparation of (bis-(trifluormethyl)-phenyl)-acetic acids and their alkyl esters as well as dialkyl esters of (bis-(trifluormethyl)-phenyl)-malonic acid

Also Published As

Publication number Publication date
GB9818661D0 (en) 1998-10-21

Similar Documents

Publication Publication Date Title
IE851937L (en) Imidazopyridines
JPS61251650A (en) Manufacture of (z)-1-phenyl-1-diethylaminocarbonyl-2- aminomethylcyclopropanehydrochloride
EP0161350A1 (en) Process for preparing benzazepines
US5034541A (en) Method of preparing 1-phenyl-1-diethylaminocarbonyl-2-phthalimidomethyl-cyclopropane-z
JPS5919536B2 (en) Method for producing 5-aroyl-1-lower alkylpyrrole-2-acetic acid derivative
US5705692A (en) Process for the preparation of iohexol
US5922906A (en) Side chains synthesis for an anthiarrhythmic compound
GB2328942A (en) Side chain synthesis for an antiarrythmic compound
US3200151A (en) Arylaminoalkyl guanidines
US3016373A (en) Process for the preparation of
US4363918A (en) Method of preparing 1-alkyl-3-carboxy-1H pyrrole-2-acetic acids
US4200759A (en) Preparation of imidazo[2,1-a]isoindole compounds
US4061644A (en) Process for the production of 2-amino-3-hydroxypyridines
US4146713A (en) Method of preparing 3-morpholino-2-cyanoacrylamide
Bachman et al. AN ATTEMPTED SYNTHESIS OF A CYCLOÖCTATETRAENE. CIS-TRANS ISOMERISM OF SUBSTITUTED DI-AND TRI-PHENYLBUTADIENES1
US3301896A (en) 1-(cyclopropylcarbonyl) ureas
JPS6054948B2 (en) Method for producing aromatic amines from α,β↓-unsaturated cycloaliphatic ketoxime
US4782075A (en) Hexahydrocarbazole containing alkylaminoamide compounds, pharmaceutical compositions and use
JPS6363658A (en) Manufacture of substituted indolinone derivative
CA1317957C (en) Process for the preparation of 1-alkyl-3-carboxy-4- cinnolones
JP2812761B2 (en) Process for the preparation of anilino fumarate via chloromaleate or chlorofumarate or mixtures thereof
US3627773A (en) 1,3,4,4A,5,9B-HEXAHYDRO-5-PHENYL-2H-INDENO{8 1,2-c{9 -PYRIDINES
US4495351A (en) Method for the production of 1-alkyl-6,7-methylene-dioxy-4(1H)-oxo-cinnolin-3-carboxylic acids
US4079079A (en) Process for the monoacylation of an aromatic primary diamine
Barber et al. A new cinnoline synthesis. Part III. Alternative routes to 4-hydroxy-6-nitrocinnoline and 4, 6-diaminocinnoline

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)